Washington, DC, United States of America

Gary J Nabel

This inventor holds 108 USPTO granted patents and 38 published patent applications, plus 12 CIPO patents and 18 EPO patents, primarily in Viral Vaccines (CPC class C07K2317-76). Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of Michigan, Sanofi. Active years: 1985-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary J Nabel. Retrieved from https://idiyas.com/inventor/gary-j-nabel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 108 (Patent Applications = 38)

% Patents Active = 83.3

CIPO Patents = 12 (Patent Applications = 17)

EPO Patents = 18 (Patent Applications = 32)

Average Co-Inventor Count = 3.8

ph-index = 21

Forward Citations = 4,335(Granted Patents)

Forward Citations (Not Self Cited) = 4,102(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Newton, MA (US) (1988)
Ann Arbor, MI (US) (1994 - 2007)
Bethesda, MD (US) (2019)
Cambridge, MA (US) (1985 - 2024)
Washington, DC (US) (2001 - 2024)
Chestnut Hill, MA (US) (2018 - 2024)
Bridgewater, NJ (US) (2021 - 2024)

Company Filing History:

48 out of 3,696

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

32 out of 3,536

University of Michigan

Dana-Farber-Cancer Institute Inc.

patents

5. 8 out of 392

Genetics Institute, Inc.

patents

6. 8 out of 16,278

USA as Represented by Secretary of the Navy

patents

7. 4 out of 2,172

University of Washington

patents

8. 2 out of 545

Glaxosmithkline Biologicals Sa

patents

9. 2 out of 71

International Aids Vaccine Initiative

patents

10. 2 out of 1,208

Scripps Research Institute

Janssen Vaccines & Prevention B.v.

patents

15. 1 out of 1

Sabin Vaccine Institute

Warner-Lambert Company

patents

18. 3 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1985-2025

Loading Chart...

Areas of Expertise:

Viral Vaccines

Chikungunya Virus

HIV Neutralizing Antibodies

Epstein-Barr Virus

Virus-Like Particles

Trispecific Binding Proteins

Bivalent Binding Proteins

Ferritin Proteins

Adenoviral Vectors

Immunogenic Responses

Polypeptides

Antibodies

108 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12454553 - Antigenic multimeric respiratory syncytial virus polypeptides (2025-10-28),

2. 12281336 - Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteins (2025-04-21),

3. 12227573 - Trispecific binding proteins, methods, and uses thereof (2025-02-18),

4. 12168675 - Virus-like particles and methods of use (2024-12-17),

5. 12121562 - Antigenic Epstein Barr virus polypeptides (2024-10-22),

6. 12071454 - Antigenic respiratory syncytial virus polypeptides (2024-08-27),

7. 12053503 - Antigenic epstein barr virus polypeptides (2024-08-06),

8. 12005115 - Epstein-barr virus vaccines (2024-06-11),

9. 11993636 - Antigenic OspA polypeptides (2024-05-28),

10. 11992523 - Method for producing chikungunya virus (CHIKV) virus-like particles comprising the C, E2, and E1 structural proteins (2024-05-28),

11. 11932704 - Trispecific and/or trivalent binding proteins (2024-03-19),

12. 11913013 - Chimpanzee adenoviral vector-based filovirus vaccines (2024-02-27),

13. 11904009 - Ferritin proteins (2024-02-20),

14. 11779651 - Bivalent, bispecific binding proteins for prevention or treatment of HIV infection (2023-10-10),

15. 11718647 - Virus-like particles and methods of use (2023-08-08),

Certainly! Here is an article about inventor Gary J Nabel:

Title: Innovator Spotlight: Gary J Nabel - Pioneering Vaccines and Ferritin Proteins

Introduction:

Gary J Nabel, a distinguished inventor, has made significant contributions in the field of vaccines and protein technology. With an impressive portfolio of 96 patents, Nabel's work has revolutionized preventative medicine. Based in Washington, DC, Nabel's innovative spirit and dedication to scientific advancement have led to groundbreaking discoveries.

Latest Patents:

1. Chimpanzee adenoviral vector-based filovirus vaccines: Nabel's invention provides vaccines that induce an immune response and protect against filovirus infections in humans. By using chimpanzee adenoviral vectors expressing filovirus proteins, the vaccine offers protection against strains of Ebolavirus and Marburg virus.

2. Ferritin proteins: Nabel's ferritin proteins, comprising mutations and immune-stimulatory moieties, have opened new possibilities in eliciting antibodies and developing antigenic responses against various pathogens.

Career Highlights:

Nabel has notably collaborated with esteemed institutions such as the University of Michigan and The United States of America, represented by the Department of Health and Human Services. His work reflects a dedication to public health and a commitment to advancing medical science for the betterment of society.

Collaborations:

Throughout his career, Nabel has collaborated with accomplished professionals such as Zhi-yong Yang and Elizabeth G Nabel. These collaborations have played a vital role in advancing his research and bringing innovative solutions to fruition.

Conclusion:

In conclusion, Gary J Nabel stands as a beacon of innovation in the field of vaccines and protein technology. His patents reflect a commitment to excellence, and his collaborations have enriched the scientific community. Nabel's contributions have not only shaped the landscape of preventative medicine but also paved the way for future advancements in the field.

Profile summary based on public USPTO records.